Six novel and three recurrent mutations in nine Austrian patients with hemophilia B.
In this report we describe the molecular basis of the factor IX (FIX) deficiency in nine patients with severe (n = 6), moderate (n = 1) or mild (n = 2) hemophilia B. The following genetic defects were identified by enzymatic amplification with the polymerase chain reaction (PCR) and subsequent direct sequencing of all exons and exon-intron-junctions: patient B.B. (FIX "Vienna I"): deletion of nucleotides 6343 to 6362; patient M.H. and W.J. (FIX "Vienna II"): nucleotide 17704 (C to G), Gln 97 to Glu; patient L.K. (FIX "Vienna III"): nucleotide 17761 (C to T), Arg 116 to stop; patient U.A. (FIX "Vienna IV"): nucleotide 10415 (C to G), Pro 55 to Ala; patient H.G. (FIX "Vienna V"): nucleotide 6488 (C to T), Thr 38 to Ile; patient H.M. (FIX "Vienna VI"): nucleotide 31276 (G to C), Trp 385 to Cys; patient L.C. (FIX "Vienna VII"): deletion of nucleotide 6700; patient S.F. (FIX "Vienna VIII"): nucleotide 10392 (A to T), Asp 47 to Val. The causative mutation was detected in the FIX gene in each of the nine patients with hemophilia B. There was one small deletion, one point deletion and seven point mutations. The latter include six missense mutations and one nonsense mutation. The mutations in Vienna III, IV and V have already been described in previous studies. The two deletions, Vienna I and Vienna VII have not been reported previously. The genetic defects observed in Vienna II, VI and VIII are novel missense mutations which result in amino acid changes at residues 97, 47 and 385, respectively.
Department of Medicine I, University of Vienna, Austria.
J
J
Walter
I
I
Pabinger-Fasching
H H
HH
Watzke
D001317:Austria; D001483:Base Sequence; D005164:Factor IX / Q000235:genetics*; D005815:Genetic Code; D002836:Hemophilia B / Q000235:genetics*; D006801:Humans; D008969:Molecular Sequence Data; D009154:Mutation
D005164:Factor IX